Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.54 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | G6PD | P11413 | 2/20 | 0.43 |
| ▸ | DHFR | P00374 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26344534 | 0.94 | MAPT (0.53) | MAPTMDM2ESR1ESR2MEN1 | |
| SCHEMBL26344503 | 0.94 | MAPT (0.51) | MAPTMDM2ESR1ESR2MEN1 | |
| SCHEMBL26344501 | 0.94 | MAPT (0.53) | MAPTMDM2ESR1ESR2MEN1 | |
| SCHEMBL26344500 | 0.92 | ESR1 (0.51) | MAPTMDM2ESR1ESR2MEN1 | |
| SCHEMBL26345103 | 0.92 | MAPT (0.50) | MAPTMDM2ESR1ESR2AOC3 | |
| SCHEMBL26344433 | 0.90 | MAPT (0.54) | MAPTMDM2ESR1ESR2MEN1 | |
| SCHEMBL26344529 | 0.90 | MAPT (0.51) | MAPTMDM2ESR1ESR2MEN1 | |
| SCHEMBL26345130 | 0.90 | MAPT (0.47) | MAPTMDM2ESR1ESR2MEN1 | |
| SCHEMBL26343746 | 0.90 | ESR1 (0.53) | MAPTESR1ESR2MEN1KMT2A | |
| SCHEMBL26344377 | 0.89 | MAPT (0.51) | MAPTMDM2ESR1ESR2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309380-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230309380-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, OR10J3, TMEM109 | MAPT 1419/4885MDM2 3751/4885ESR1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.